Prevention & care
Abnormal menstrual bleeding: patterns, heavy periods, testing and treatment choices
On this page
Abnormal uterine bleeding describes changes in bleeding from the womb: how much, how long, how often or how predictably it happens. It describes a symptom pattern, not its cause. Pregnancy-related bleeding needs a different assessment.[1]
Describe the pattern before naming a cause
Heavy bleeding, prolonged bleeding, irregular cycles and bleeding between periods are different descriptions. FIGO separates those symptom descriptions from its classification of possible causes. Several causes can coexist; a label such as heavy menstrual bleeding does not establish fibroids or a hormone disorder.[2]
Daily life matters more than a perfect volume measurement
Needing frequent product changes, using two products together, leaking onto clothes or bedding, passing large clots, or avoiding ordinary activities can help describe heavy periods. Tiredness or breathlessness may prompt assessment for anemia. Tell the clinician what bleeding interrupts, rather than waiting until you can measure milliliters.[3]
Sudden heavy bleeding needs a severity assessment
Seek emergency care for bleeding with faintness, chest pain or breathing difficulty. ACOG gives changing a pad or tampon hourly for over two hours with these symptoms as an example requiring emergency attention; it is not a rule for waiting until that amount is reached.[1]
Acute heavy uterine bleeding can threaten circulation. Clinical assessment first checks blood loss and stability; controlling the episode and preventing recurrence are separate goals. The acute-care guideline concerns nonpregnant people of reproductive age, not bleeding in pregnancy or after delivery.[4]
Pregnancy possibility and menopause change the pathway
A missed period with unusual bleeding and abdominal or pelvic pain needs urgent assessment for a possible ectopic pregnancy. Bleeding between periods or after sex should be checked, even when contraception seems a plausible explanation. The source can be the cervix or vagina as well as the womb.[5]
Bleeding after menopause warrants assessment even once or in a small amount. The menopause and endometrial-cancer guides explain that pathway.[6]
Separate structural findings from other mechanisms
FIGO groups polyps, adenomyosis, fibroids and lining overgrowth or malignancy as structural categories. Other categories include clotting disorders, ovulation disturbance, lining-related dysfunction and treatment-related bleeding. A scan finding can coexist with another explanation, so discovering a fibroid does not finish the whole assessment.[2]
Choose investigations from the history
NICE recommends a full blood count for heavy menstrual bleeding. Bleeding since periods began plus a personal or family bleeding history may prompt clotting-disorder testing. Routine female hormone testing is not recommended for heavy bleeding; thyroid tests are directed by other suggestive symptoms. History and examination guide ultrasound or hysteroscopy rather than everyone receiving the same test.[7]
Heavy bleeding from the first periods can be informative
ACOG adolescent guidance includes assessment for anemia, including ferritin, ovulation-related endocrine causes and bleeding disorders. Suspected clotting problems may need gynecology and hematology working together. Heavy bleeding in adolescence should not automatically be dismissed as an immature cycle, and a severe acute episode still requires assessment of circulation.[8]
Discuss bleeding control, contraception and fertility together
NICE places preferences, accompanying pain, other conditions and findings at the center of treatment choice. Options may include a levonorgestrel-releasing intrauterine system, other hormonal treatment, tranexamic acid or anti-inflammatory medicines. Suitability and contraindications differ. Ask whether an option is contraceptive, how it affects future pregnancy, and when response will be reviewed.[7]
A short record can make the consultation more useful
Record bleeding days, spotting between periods, product changes, pain and effects on work or sleep. Bring details of contraception, hormonal medicines and other medicines. This helps describe the pattern and possible treatment-related causes; a diary does not need to delay seeking help for concerning bleeding.[1]
Evidence & uncertainty
Treatment evidence concerns particular causes, devices and outcomes. A 2020 review found that a hormone-releasing intrauterine system may improve heavy bleeding and quality of life compared with other medicines, but certainty varied and comparisons with surgery remained less clear.[10]
Selected-source overview · Independent review pendingPublished questions
Are heavy periods and irregular periods the same problem?
Selected-source overview · Independent review pending. Read the evidence context.
No. Amount, duration, frequency and predictability describe different aspects of bleeding. Either pattern can have several causes, and more than one pattern may occur together.[2]
Evidence behind this answer
- The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes: 2018 revisions
classification consensus · 2018
Relevant original source text read; no independent full evidence appraisal · Sections 3–4: symptom terminology versus PALM-COEIN causes; coexistence
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Must I measure blood loss before asking for help?
Selected-source overview · Independent review pending. Read the evidence context.
No. Frequent product changes, leaks, missed activities and fatigue are useful descriptions. Impact on daily life is a valid reason to seek assessment.[3]
Evidence behind this answer
- Heavy periods
agency patient explanation · Date not stated
Relevant original source text read; no independent full evidence appraisal · Signs, daily-life impact and anemia symptoms
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Do clots during a period identify the cause?
Selected-source overview · Independent review pending. Read the evidence context.
No. Clots can help describe heavy bleeding, but symptoms alone do not distinguish ovulation changes, growths, medicines or other causes.[1]
Evidence behind this answer
- Abnormal Uterine Bleeding
professional society patient explanation · Date not stated
Relevant original source text read; no independent full evidence appraisal · Original FAQ: patterns, acute warning example, causes and tracking
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Will a large hormone panel usually explain heavy periods?
Selected-source overview · Independent review pending. Read the evidence context.
Not necessarily. NICE advises against routine female hormone tests for heavy menstrual bleeding and limits thyroid testing to people with other suggestive symptoms. Tests should answer a specific clinical question.[7]
Evidence behind this answer
- Heavy menstrual bleeding: assessment and management, NG88
clinical guideline · 2026-07-07
Relevant original source text read; no independent full evidence appraisal · Recommendations 1.1–1.5; full blood count, selected clotting/thyroid tests, investigations and shared treatment choices; updated 7 July 2026
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Why might a teenager with heavy periods have ferritin checked?
Selected-source overview · Independent review pending. Read the evidence context.
Ferritin helps assess iron stores. ACOG adolescent guidance includes it when evaluating anemia from heavy bleeding, alongside possible endocrine and bleeding-disorder causes. This is an adolescent assessment recommendation, not a universal laboratory panel.[8]
Evidence behind this answer
- Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding, Committee Opinion 785
clinical guideline · 2019
Original complete abstract and reaffirmation header read; linked full journal manuscript not read · Original complete abstract: adolescent ferritin, endocrine/coagulation assessment and collaboration; reaffirmed 2023
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Why does bleeding since my first periods matter?
Selected-source overview · Independent review pending. Read the evidence context.
It can raise suspicion of a bleeding disorder, especially with a personal or family bleeding history. That history may change which tests or specialists are needed.[7]
Evidence behind this answer
- Heavy menstrual bleeding: assessment and management, NG88
clinical guideline · 2026-07-07
Relevant original source text read; no independent full evidence appraisal · Recommendations 1.1–1.5; full blood count, selected clotting/thyroid tests, investigations and shared treatment choices; updated 7 July 2026
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does stopping an acute bleeding episode finish treatment?
Selected-source overview · Independent review pending. Read the evidence context.
Not always. The acute-care guideline separates immediate stabilization and bleeding control from longer-term maintenance. The underlying cause, contraindications and future pregnancy plans still need attention.[4]
Evidence behind this answer
- Management of Acute Abnormal Uterine Bleeding in Nonpregnant Reproductive-Aged Women, Committee Opinion 557
clinical guideline · 2013
Original complete abstract and reaffirmation header read; linked full journal manuscript not read · Original complete abstract: circulation first, acute control versus maintenance; displayed reaffirmation 2026
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Can contraception be connected with unexpected bleeding?
Selected-source overview · Independent review pending. Read the evidence context.
Yes. Hormonal contraception can cause bleeding between periods, but it should not automatically be assumed responsible. New or unusual bleeding still needs assessment for other causes.[5]
Evidence behind this answer
- Vaginal bleeding between periods or after sex
agency patient explanation · Date not stated
Relevant original source text read; no independent full evidence appraisal · Assessment, possible sources, contraception and urgent missed-period/pain combination
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does a better two-year result mean one treatment stays better forever?
Selected-source overview · Independent review pending. Read the evidence context.
No. In the ECLIPSE trial, the early quality-of-life advantage was no longer statistically clear at five years, and treatment changes were common. Follow-up duration and continued use matter.[9]
Evidence behind this answer
- A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system ...: the ECLIPSE trial
randomized trial report · 2015
Original report record and complete structured abstract read; linked 118-page report not read · Original structured report abstract: 571 participants, 2-year/5-year MMAS outcomes, treatment changes
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does research on a hormonal coil apply to every intrauterine device?
Selected-source overview · Independent review pending. Read the evidence context.
No. The Cochrane review evaluated a specific levonorgestrel system. Different devices and doses should not be assumed to have identical evidence for heavy menstrual bleeding.[10]
Evidence behind this answer
- Progestogen-releasing intrauterine systems for heavy menstrual bleeding
systematic review · 2020
Relevant original source text read; no independent full evidence appraisal · Original plain-language summary and full abstract: 25 RCTs, June 2019 search, device scope and GRADE limitations
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
A trial measured the effect on everyday life
ECLIPSE randomized 571 primary-care patients with heavy menstrual bleeding to a levonorgestrel intrauterine system or usual medical treatment. The condition-specific quality-of-life score favored the system over two years by 13.4 points (95% interval 9.9–16.9). At five years, the difference was no longer statistically clear; many participants had changed or stopped treatment. This compares initial strategies, not permanent use of the same treatment in everyone.[9]
Device evidence does not cover every product or cause
The Cochrane review included 25 trials with 2,511 participants, searched through June 2019. All evaluated a particular levonorgestrel system, so results cannot simply be transferred to every hormonal device. Evidence certainty ranged from very low to moderate; bleeding reduction, satisfaction, adverse effects and avoiding later procedures are different outcomes. The review includes ECLIPSE, rather than providing a second independent replication of it.[10]
References
- Abnormal Uterine Bleeding
Professional society patient explanation
ACOG · Content/publication date: not stated
Accessed: 2026-10-20 UTC · Relevant original source text read; no independent full evidence appraisal
Cited sections: Original FAQ: patterns, acute warning example, causes and tracking - The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes: 2018 revisions
Classification consensus
Munro MG, Critchley HOD, Fraser IS / FIGO · Content/publication date: 2018
Accessed: 2026-10-20 UTC · Relevant original source text read; no independent full evidence appraisal
Cited sections: Sections 3–4: symptom terminology versus PALM-COEIN causes; coexistence - Heavy periods
Agency patient explanation
NHS · Content/publication date: not stated
Accessed: 2026-10-20 UTC · Relevant original source text read; no independent full evidence appraisal
Cited sections: Signs, daily-life impact and anemia symptoms - Management of Acute Abnormal Uterine Bleeding in Nonpregnant Reproductive-Aged Women, Committee Opinion 557
Clinical guideline
ACOG · Content/publication date: 2013
Accessed: 2026-10-20 UTC · Original complete abstract and reaffirmation header read; linked full journal manuscript not read
Cited sections: Original complete abstract: circulation first, acute control versus maintenance; displayed reaffirmation 2026 - Vaginal bleeding between periods or after sex
Agency patient explanation
NHS · Content/publication date: not stated
Accessed: 2026-10-20 UTC · Relevant original source text read; no independent full evidence appraisal
Cited sections: Assessment, possible sources, contraception and urgent missed-period/pain combination - Postmenopausal bleeding
Agency patient explanation
NHS · Content/publication date: not stated
Accessed: 2026-10-20 UTC · Relevant original source text read; no independent full evidence appraisal
Cited sections: Check any postmenopausal vaginal bleeding; necessary scope boundary only - Heavy menstrual bleeding: assessment and management, NG88
Clinical guideline
NICE · Content/publication date: 2026-07-07
Accessed: 2026-10-20 UTC · Relevant original source text read; no independent full evidence appraisal
Cited sections: Recommendations 1.1–1.5; full blood count, selected clotting/thyroid tests, investigations and shared treatment choices; updated 7 July 2026 - Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding, Committee Opinion 785
Clinical guideline
ACOG · Content/publication date: 2019
Accessed: 2026-10-20 UTC · Original complete abstract and reaffirmation header read; linked full journal manuscript not read
Cited sections: Original complete abstract: adolescent ferritin, endocrine/coagulation assessment and collaboration; reaffirmed 2023 - A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system ...: the ECLIPSE trial
Randomized trial report
Gupta JK and colleagues · Content/publication date: 2015
Accessed: 2026-10-20 UTC · Original report record and complete structured abstract read; linked 118-page report not read
Cited sections: Original structured report abstract: 571 participants, 2-year/5-year MMAS outcomes, treatment changes - Progestogen-releasing intrauterine systems for heavy menstrual bleeding
Systematic review
Bofill Rodriguez M, Lethaby A, Jordan V / Cochrane · Content/publication date: 2020
Accessed: 2026-10-20 UTC · Relevant original source text read; no independent full evidence appraisal
Cited sections: Original plain-language summary and full abstract: 25 RCTs, June 2019 search, device scope and GRADE limitations
Scope & review
- Population
- People with abnormal menstrual bleeding; nonpregnant reproductive-age assessment distinguished from pregnancy and postmenopausal pathways
- Exposure or intervention
- History-directed testing and shared choices for acute or persistent bleeding
- Comparison
- Different causes and medical strategies; two versus five-year trial follow-up
- Outcomes
- Daily-life impact, anemia, bleeding control, treatment changes and fertility-related choices
- Timeframe
- Source-specific publication, update and search dates remain separate; checked 2026-10-20 UTC
- Jurisdiction
- UK NICE/NHS, US ACOG and international FIGO; local pathways and medicine availability vary
Targeted original-source reading and comparison with current guide bodies, tables and FAQs. Claim-linked selected recommendations and study findings are educational synthesis, not a systematic search, independent evidence grade or qualified clinical review.
Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.
Revision history
- 2026-10-20 UTC: New symptom guide drafted after source verification, existing-scope comparison and cumulative attribution audit; qualified review pending.
- 2026-10-20 UTC: Checked explicit foundation/evidence/uncertainty phases,canonical related IDs,consumer FAQ wording,source-fit and actual cumulative attribution. Added source-supported emergency-plan nuance and preserved source access limits; no qualified signoff.
What this article still leaves open
- Cause-specific treatment, pregnancy/postpartum bleeding and detailed postmenopausal investigation belong to separate clinical pathways.
- This targeted review does not compare every device, medicine, procedure or fertility outcome.
Suggest a correction
Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.
Your submitted corrections for this article
Explore the topic map
Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.